A Novel Miniature Equine-Assisted Diabetes Education Program for Youth: Evaluating the Diabetes Equine Empowerment Program (DEEP).

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-20
SponsorNemours Children's Clinic

About this trial

The Diabetes \& Equine Empowerment Program (DEEP) is a research study evaluating a novel diabetes education program that combines hands-on interactions with miniature horses and evidence-based diabetes self-management education for youth ages 8-20 years with diabetes. Participants and their caregivers attend four structured educational sessions led by a diabetes specialist and a certified equine specialist. Topics include diabetes self-management, coping skills, problem-solving, self-advocacy, and transition readiness. Researchers will evaluate whether the program is feasible to deliver, acceptable to participants and families, and helpful in supporting engagement in diabetes care. Participants will be followed for up to six months after the program, and study outcomes include satisfaction, diabetes-related distress, self-care behaviors, clinic attendance, and diabetes technology use.

In simple terms, this study is exploring whether learning about diabetes through guided activities with miniature horses can help children, adolescents, and young adults feel more confident in managing their diabetes, improve self-care skills, and become more engaged in their health care. The goal is to determine whether this innovative educational approach is practical to offer and valued by patients, families, and health care providers.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 8 to 20 years

Diagnosis of type 1 or type 2 diabetes

Most recent HbA1c greater than 9.0% OR no diabetes clinic follow-up for more than 6 months

English-speaking participant and caregiver

Disqualifiers

Non-English-speaking participant or caregiver

Medical, physical, cognitive, or behavioral condition that would prevent safe participation in study activities

Significant fear of horses that would limit participation

Allergy to horses that would limit participation

Trial design

Design model

Single group

Treatments tested in this trial

  • Diabetes & Equine Empowerment Program (DEEP)

    Behavioral

    The Diabetes \& Equine Empowerment Program (DEEP) is a behavioral and educational intervention that combines evidence-based diabetes self-management education with structured, hands-on interactions involving miniature horses. Youth with diabetes and their caregivers participate in four facilitated sessions led by a diabetes specialist and a certified equine specialist. Session activities are designed to reinforce diabetes self-management skills, coping strategies, problem-solving, communication, self-advocacy, and transition readiness through experiential learning. The intervention aims to improve participant engagement, confidence in diabetes management, and readiness for increasing independence while providing a supportive and interactive learning environment. The program is being evaluated for feasibility, acceptability, participant satisfaction, and potential effects on psychosocial and behavioral outcomes.

Treatment groups

50 Participants
are divided into 1 treatment group
Group A: Diabetes & Equine Empowerment Program (DEEP)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Participant Recruitment Rate

Recruitment feasibility will be assessed by the proportion of eligible participants who enroll in the four-session miniature equine-assisted diabetes education program, as documented in study enrollment records.

Time frame
From study initiation through completion of enrollment (approximately 9 months)
2

Participant Retention Rate

Retention feasibility will be assessed by the proportion of enrolled participants who remain in the study and complete scheduled study assessments, as documented in study records.

Time frame
From enrollment through completion of study participation (approximately 9 months)
3

Program Attendance Rate

Attendance feasibility will be assessed by the proportion of scheduled miniature equine-assisted diabetes education sessions attended by participants, as documented in program attendance logs.

Time frame
From enrollment through completion of study participation (approximately 9 months)
4

Program Completion Rate

Completion feasibility will be assessed by the proportion of enrolled participants who complete all four miniature equine-assisted diabetes education sessions.

Time frame
From enrollment through completion of study participation (approximately 9 months)

Secondary outcomes

1

Change in Diabetes Distress Assessed by the Problem Areas in Diabetes Questionnaires (PAID-C/PAID-T)

Change in diabetes-related emotional distress among youth participants as measured by the Problem Areas in Diabetes questionnaires, including the PAID-C for participants ages 8-12 years and the PAID-T for participants ages 13-17 years. Higher scores indicate greater diabetes-related distress

Time frame
Baseline to immediately after completion of the four-session DEEP program
2

Change in Diabetes Self-Management Behaviors Assessed by the Self-Care Inventory-Updated (SCI-U)

Change in diabetes self-management behaviors as measured by the Self-Care Inventory-Updated (SCI-U), a validated self-report questionnaire that assesses adherence to diabetes self-care activities, including blood glucose monitoring, medication administration, and diabetes-related self-management tasks. Higher scores indicate better adherence to the diabetes care plan.

Time frame
Baseline to immediately after completion of the four-session DEEP program
3

Routine Diabetes Appointment Attendance Assessed by Electronic Health Record Review

Change in routine diabetes clinic appointment attendance as assessed through electronic health record review. Attendance will be evaluated by comparing the proportion of scheduled diabetes clinic visits attended before participation and following completion of the DEEP program

Time frame
Six months before participation through six months after program completion
4

Diabetes Technology Initiation Assessed by Electronic Health Record Review

The number of participants who initiate diabetes technology, including continuous glucose monitoring and/or insulin pump therapy, within six months following program completion, as documented through electronic health record review.

Time frame
Program completion through six months after program completion

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Nemours Children's Clinic

Lead sponsor

Nemours Children's Health System

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: